Show simple item record

dc.contributor.advisorWalker, Logan
dc.contributor.advisorMerriman, Tony
dc.contributor.authorCoufal, Nicole Jessica
dc.date.available2014-07-29T22:58:33Z
dc.date.copyright2014
dc.identifier.citationCoufal, N. J. (2014). DNA Copy Number Variation and BRCAx Hereditary Breast Cancer (Thesis, Master of Science). University of Otago. Retrieved from http://hdl.handle.net/10523/4934en
dc.identifier.urihttp://hdl.handle.net/10523/4934
dc.description.abstractBreast cancer is the second most deadly cancer for New Zealand (NZ) women aged between 25-75 years. Breast cancer generally exhibits familial aggregation, consistent with variation in genetic susceptibility to the disease. However, known susceptibility genes only account for less than 25% of the familial risk of breast cancer. The remaining genetic variance is likely to be due to variants conferring more moderate risks. To identify further breast cancer susceptibility alleles, 24 BRCAx (no pathogenic breast cancer 1, early onset (BRCA1) and breast cancer 2, early onset (BRCA2) mutations) probands from breast cancer families, 644 healthy female controls and 626 healthy male controls were fine-mapped for copy number variants (CNVs). Genome wide scanning of DNA germline CNVs was performed using Illumina Human1M-duo V3 beadchip single nucleotide polymorphism (SNP) array and the PennCNV calling algorithm; many novel CNVs were validated by quantitative PCR. In the array data, rare CNVs that were deletions were found only in the BRCAx cases, but not in the healthy controls. These rare deletions overlapped 15 genes (13 loci) that were all predicted to be disrupted: ANKRD45, DTX2, PDXDC1, PIK3C2G, PRAME, SLC9C2, RHD, TBC1D5, TMEM106B, UPK3B, CKM, KLKB1, SELP, SEMA7A and SPINT4. The first ten CNV events are suggested to be of low to moderate risk of breast cancer susceptibility. Many of these genes above belong to several biological pathways, for example TP53, oestrogen/progesterone signalling, and Fanconi Anemia (Fanconi Anemia is an autosomal recessive genetic disorder), and many of these genes have already been reported in relation to breast cancer pathogenesis and other cancers. These findings support an association between these rare CNVs and the genes they overlap. Further studies are warranted to assess definitively the role and susceptibility risk of these CNVs and genes in hereditary breast cancer development.
dc.language.isoen
dc.publisherUniversity of Otago
dc.rightsAll items in OUR Archive are provided for private study and research purposes and are protected by copyright with all rights reserved unless otherwise indicated.
dc.subjectnon-BRCA1/2
dc.subjectBreast cancer
dc.subjectCopy Number Variation
dc.subjectCNV
dc.subjectdeletion
dc.subjectfamilial
dc.subjecthereditary
dc.subjectrisk
dc.subjectgenome wide
dc.subjectcancer
dc.titleDNA Copy Number Variation and BRCAx Hereditary Breast Cancer
dc.typeThesis
dc.date.updated2014-07-29T05:07:25Z
dc.language.rfc3066en
thesis.degree.disciplineBiochemistry
thesis.degree.nameMaster of Science
thesis.degree.grantorUniversity of Otago
thesis.degree.levelMasters
otago.interloanyes
otago.openaccessAbstract Only
 Find in your library

Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item is not available in full-text via OUR Archive.

If you would like to read this item, please apply for an inter-library loan from the University of Otago via your local library.

If you are the author of this item, please contact us if you wish to discuss making the full text publicly available.

This item appears in the following Collection(s)

Show simple item record